Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/15/1997 | EP0801069A1 Process for the preparation of clavulanic acid |
10/15/1997 | EP0801067A1 Novel quinuclidine derivatives and medicinal composition thereof |
10/15/1997 | EP0801060A1 Heterocyclic Beta-3 Adrenergenic Agonists |
10/15/1997 | EP0801059A1 Indole derivative |
10/15/1997 | EP0800829A1 Antitumor agent potentiator comprising il-6 antagonist |
10/15/1997 | EP0800826A2 Apoptosis-controlling agent |
10/15/1997 | EP0800825A1 Stable aqueous solutes containing carotenoids and vitamins |
10/15/1997 | EP0800824A1 Stable carotenoid emulsions for parenteral administration |
10/15/1997 | EP0800823A1 Anti-cariogenic activity of erythritol |
10/15/1997 | EP0800821A2 Compositions comprising benzoyl peroxide and diethylene glycol monoethyl ether; method for their preparation |
10/15/1997 | EP0800820A2 Cosmetic composition comprising a pasty fatty material and volatile compounds |
10/15/1997 | EP0800584A1 Arachidonic acid and methods for the production and use thereof |
10/15/1997 | EP0800580A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases |
10/15/1997 | EP0800528A1 Peptide and peptide analog protease inhibitors |
10/15/1997 | EP0800524A1 6- triazolyl 3-(trifluoromethyl)phenyl]methyl]-2-quinolinones and -quinolinethiones |
10/15/1997 | EP0800520A1 Process for the preparation of lamotrigine |
10/15/1997 | EP0800519A1 Steroid receptor modulator compounds and methods |
10/15/1997 | EP0800517A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity |
10/15/1997 | EP0800516A1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED (b)-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME |
10/15/1997 | EP0800515A1 DIBENZ cd,f]INDOLE DERIVATIVES |
10/15/1997 | EP0800514A1 Substituted imides as tnf inhibitors |
10/15/1997 | EP0800512A1 Antiherpes peptidomimetic compounds |
10/15/1997 | EP0800510A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases |
10/15/1997 | EP0800505A1 Novel immunotherapeutic aryl amides |
10/15/1997 | EP0800504A1 Tricyclic retinoids, methods for their production and use |
10/15/1997 | EP0800503A1 Novel trienoic retinoid compounds and methods |
10/15/1997 | EP0800400A1 Germanium yeast human diet nutritional supplement |
10/15/1997 | EP0800399A1 Combined therapeutical treatment of hyperproliferative diseases |
10/15/1997 | EP0800397A1 Bone mass anabolic composition comprising olpadronate |
10/15/1997 | EP0800396A1 Treatment of hyperandrogenic conditions |
10/15/1997 | EP0800395A1 Fibrinogen receptor antagonists |
10/15/1997 | EP0800394A1 Prevention of adverse behaviour, diarrhoea, skin disorders and infections of the hind gut associated with acidic conditions in humans and animals |
10/15/1997 | EP0800393A1 4,4-(disubstituted)cyclohexan-1-one monomers and related compounds |
10/15/1997 | EP0800392A1 Pharmaceutical preparations containing nifedipine and process for producing it |
10/15/1997 | EP0800391A1 Benzimidazoles as inhibitors of calcitriol metabolism |
10/15/1997 | EP0800390A1 Cyclopropylpyrroloindole-oligopeptide anticancer agents |
10/15/1997 | EP0800389A1 Novel compounds |
10/15/1997 | EP0800388A1 Compounds for veterinary and medicinal applications |
10/15/1997 | EP0800387A1 Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours |
10/15/1997 | EP0800386A1 Transdermal system for the simultaneous delivery of a number of active principles |
10/15/1997 | EP0800385A1 Oral sustained-release preparation |
10/15/1997 | EP0800384A1 Pharmaceutical tablet formulations for direct compression |
10/15/1997 | EP0800383A1 Proliposome powders for inhalation |
10/15/1997 | EP0800382A1 Compositions for the treatment of dermatological disorders and methods for their use |
10/15/1997 | EP0800364A1 Transdermal administration of apomorphine |
10/15/1997 | EP0772396A4 Method of regulating immune function |
10/15/1997 | EP0712404B1 Benzothiophene analogs as antiviral agents |
10/15/1997 | EP0701556B1 N-((1-(4-fluorophenoxy)butyl)-4-piperidinyl)-n-methylamino-2-benzothiazolols as class iii antiarrhythmic agents |
10/15/1997 | EP0684950A4 Chemical compounds useful in photodynamic therapy and production of laser light. |
10/15/1997 | EP0654032B1 Quinuclidine derivatives as squalene synthase inhibitors |
10/15/1997 | EP0642583B1 Methods and compositions for increasing the sensitivity of a cell to a dna damaging agent |
10/15/1997 | EP0598770B1 New pyrazine derivatives, their preparation and their use |
10/15/1997 | EP0573542B1 Imidazole-derivatives having antagonistic activity on the histamine h3-receptor |
10/15/1997 | EP0546102B1 Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases |
10/15/1997 | EP0537269B1 Immunosuppressive compounds |
10/15/1997 | EP0522173B1 4-desoxy-4-epipodophyllotoxin derivatives or pharmaceutically acceptable salts thereof |
10/15/1997 | EP0294469B1 Vaccines and diagnostic assays for haemophilus influenzae |
10/15/1997 | CN1162339A Polysaccharides having high iduronic acid content |
10/15/1997 | CN1162313A Substituted tetracyclic azepine derivatives having affinity for 5-HT2 receptors |
10/15/1997 | CN1162312A Phenyloxazolidinone antimicrobials |
10/15/1997 | CN1162311A Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
10/15/1997 | CN1162310A Bicyclic amidine derivatives used in therapy |
10/15/1997 | CN1162301A Compounds for the suppression of HIV TAT transactivation |
10/15/1997 | CN1162266A Novel brain endothelial cell protein and methods for its use |
10/15/1997 | CN1162264A Use of corticosteroid to reduce adverse effects of perfluorochemical emulsion |
10/15/1997 | CN1162263A Cisapride extended release oral compositions |
10/15/1997 | CN1162262A Antiinflammatory agent for external use |
10/15/1997 | CN1162261A Use of anti-VEGF agents in the treatment of endometriosis |
10/15/1997 | CN1162259A 药物组合物 The pharmaceutical composition of |
10/15/1997 | CN1162246A Ionene polymers containing biologically-active anions |
10/15/1997 | CN1161972A 4-trifluoromethyl-3-ketosteroid compound and synthesizing method thereof |
10/15/1997 | CN1161968A Pyridine condensed thienyl- and furyl-oxazolidinone compounds |
10/15/1997 | CN1161967A Preparation method for imidazole derivatives |
10/15/1997 | CN1161964A Substituted thienyl-alkenyl-carboxylic-guanidine, preparation method, use as medicine and diagnosticum and medicine containing same |
10/15/1997 | CN1161960A Ortho-substituted benzoylguanidine, preparation method, use as medicine or diagnostic reagent and medicine containing same |
10/15/1997 | CN1161957A Method for separating tramadol raceme |
10/15/1997 | CN1161836A Cream for treating tinea cruris |
10/15/1997 | CN1161835A Lactic norfloxacini and preparation method thereof |
10/15/1997 | CN1161834A Prepration method for medicinal composition containing triazolyl derivative |
10/15/1997 | CN1036119C Compound preparation of medicine for treating optic atrophy |
10/15/1997 | CA2202564A1 Hypoglycemic agent |
10/14/1997 | USRE35631 Reacting 3-bromopropylphthalimide with ethylacetoacetate, then with diazonium salt of p-anisidine yields an indole which is treated with sodium hydroxide and sulfuric acid, then hydrolysis and treatment with acetic anhydride |
10/14/1997 | US5677469 Process for resolving chiral acids with 1-aminoindan-2-ols |
10/14/1997 | US5677466 Labelled fibrinogen receptor antagonists, the use thereof and processes for preparing them |
10/14/1997 | US5677462 Process for preparing taxane derivatives |
10/14/1997 | US5677461 Complexing picolinic acid with chromium compound under a ph from 3.5 to 4.2 |
10/14/1997 | US5677456 Quinolone derivatives and processes for the preparation thereof |
10/14/1997 | US5677451 Controlling cell differentiation; skin disorders; anticancer agents |
10/14/1997 | US5677449 Pesticides |
10/14/1997 | US5677448 Sulfonamidocarboxamides |
10/14/1997 | US5677443 Bioavailable crystalline form of cefuroxime axetil |
10/14/1997 | US5677439 Prevention gene expression |
10/14/1997 | US5677428 Mono- or polyclonal antibody raised against human double-stranded rna adenosine deaminase |
10/14/1997 | US5677352 Polyamines and anti-diarrheal and gastrointestinal anti-spasmodic pharmaceutical compositions and methods of treatment |
10/14/1997 | US5677351 Sterically hindered tetraamines and method for their production |
10/14/1997 | US5677350 Inhibition of cancer cell growth, proliferation, and metastasis using N,N'-dα,ω-diaminoalkanes |
10/14/1997 | US5677349 Adminstering in the treatment of stroke and dementia |
10/14/1997 | US5677348 Substituted aminoguanidines and methods of use thereof |
10/14/1997 | US5677346 Treating urinary incontinence using (S)-desethyloxybutynin |
10/14/1997 | US5677344 Administering a sulfonyl urea or quinine |